NeuroPace
[PRIVATE]Service & Cobot Robotics · HQ: Mountain View, California · 1 model registered · 3 deployments
As of Sep 2026, DEPLOY verifies NeuroPace: 1 model, 3 deployments across 3 regions. 1 source back the record.
Ownership
PRIVATE
Capital / Funding
Undisclosed
Headquarters
Mountain View, California
IP / Patents
Undisclosed
Platform Models
1
Audited Incidents
0
Overview
NeuroPace (NASDAQ: NPCE) is a Mountain View-based medical device company that developed the RNS System, the only FDA-approved brain-responsive neuromodulation device for treating drug-resistant focal epilepsy. Over 8,000 patients implanted. FY2025 revenue: 00M (25% YoY growth). 230+ Level 4 Comprehensive Epilepsy Centers in the US.
Clean safety record across 3 verified deployments. Limited public funding data for capital position assessment.
Key Facts
Safety & Regulatory Posture
No incidents on record for NeuroPace.
Leadership & Founders
Current Program Leadership & Executives
CEO
Partnerships & Commercial Deployments
Key Recurring Partners
Recent Verified Partnerships
- Partnership
MOST RECENT
Operator Customers & Fleet Integrators
Platform Models
Deployments
- RNS System at United States (comprehensive epilepsy centers)[OPERATIONAL]
United States (comprehensive epilepsy centers) · Jun 1, 2024
- RNS System at Los Angeles, California, USA[OPERATIONAL]
Los Angeles, California, USA · Dec 1, 2013
- RNS System at United States (comprehensive epilepsy centers nationwide)[OPERATIONAL]
United States (comprehensive epilepsy centers nationwide) · Nov 1, 2013
Sectors & Applications
FAQ
What is NeuroPace?
NeuroPace (NASDAQ: NPCE) is a Mountain View-based medical device company that developed the RNS System, the only FDA-approved brain-responsive neuromodulation device for treating drug-resistant focal epilepsy. Over 8,000 patients implanted. FY2025 revenue: 00M (25% YoY growth). 230+ Level 4 Comprehensive Epilepsy Centers in the US.
What does NeuroPace make?
NeuroPace has 1 robot model on the DEPLOY registry: RNS System (NeuroPace builds physical robots).
Is NeuroPace publicly traded?
No. NeuroPace is privately held and not publicly traded, per the DEPLOY registry.
Who competes with NeuroPace?
On the DEPLOY registry, peer companies to NeuroPace building in the same form factors include Google, Samsung Electronics, Butterfly Network, Abbott.
Who is the CEO of NeuroPace?
Joel Becker is the ceo of NeuroPace, per the DEPLOY registry.
How can I invest in NeuroPace?
NeuroPace is a private company; its shares are not available on public markets, so retail investors cannot buy the stock today.
Where is NeuroPace headquartered?
NeuroPace is headquartered in Mountain View, California, USA.
Who owns NeuroPace?
NeuroPace is privately held; ownership sits with its founders and private investors.
Where does NeuroPace operate robots?
NeuroPace operates 3 verified deployments, including at United States (comprehensive epilepsy centers), Los Angeles, California, USA, United States (comprehensive epilepsy centers nationwide).
How many robots has NeuroPace deployed?
DEPLOY has 3 verified NeuroPace deployments on record at sites including United States (comprehensive epilepsy centers), Los Angeles, California, USA, United States (comprehensive epilepsy centers nationwide). That is a count of distinct field deployments each backed by sourced evidence, not a manufacturer's claimed unit total; it updates as new sites are verified.
Is NeuroPace a top robotics company?
On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, NeuroPace ranks in roughly the top 60% of companies tracked by the registry.
Is NeuroPace safe?
NeuroPace has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.